-
Ferring Announces Recipients of Innovation Grants Program 2017-2018
in PRESS RELEASE 2018 onFerring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute…
-
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
in PRESS RELEASE 2018 onFerring Pharmaceuticals announced today that it has entered into a worldwide license agreement with Ligand Pharmaceuticals to use…
-
Global agreement with FKD to commercialise novel gene therapy for bladder cancer patients
in TIMELINES onLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0 -
Acquisition of Rebiotix Inc. Microbiota Restoration Therapy
in TIMELINES onLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Ferring and the Chinese Academy of Sciences collaborate to advance research in reproductive medicine
in PRESS RELEASE 2018 onFerring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic…
-
Launch of Testavan® (testosterone)
in TIMELINES onLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Launch of REKOVELLE® (follitropin delta)
in TIMELINES onLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
FDA approves Ferring’s CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution for colonoscopy prep
in PRESS RELEASE 2017 onThe U.S. Food and Drug Administration (FDA) has granted Ferring Pharmaceuticals Inc. approval to market CLENPIQ™ (sodium picosulfate,…
-
New Ferring and Aché Laboratórios Farmacêuticos facility opens to optimise drug delivery using nanotechnology
in PRESS RELEASE 2017 onFerring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced the inauguration of their joint nanotechnology centre in São Paulo…
-
Ferring receives Swiss approval for Rekovelle®, the first personalised fertility treatment using an approved dosing algorithm
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today that Swissmedic has approved Rekovelle® (follitropin delta) for use in controlled stimulation…
Author archive for pulse
Articles by: pulse
